Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane

Kidney International

Volumn 66, Issue 3, 2004, Pages 1257-1265

  Mortier, Siska ^a   Faict, Dirk ^b   Schalkwijk, Casper G ^b   Lameire, Norbert H ^b   De Vriese, An S ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

AGE; Biocompatibility; Neoangiogenesis; Peritoneal membrane; VEGF

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINO ACID; BALANCED SALT SOLUTION; BICARBONATE; DIANEAL; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; LACTIC ACID; METHYLGLYOXAL; NUTRINEAL; PERITONEAL DIALYSIS FLUID; PHYSIONEAL; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CAPILLARY PROLIFERATION; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBROSIS; LONG TERM EXPOSURE; MEMBRANE DAMAGE; MESOTHELIUM; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ULTRAFILTRATION;

EID: 4344696765     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00879.x     Document Type: Article

References (37)

1. DE VRIESE AS, MORTIER S, LAMEIRE NH: What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 21 (Suppl 3):S9-S18, 2001
2. SEO MJ, OH SJ, KIM SI, et al: High glucose dialysis solutions increase synthesis of vascular endothelial growth factors by peritoneal vascular endothelial cells. Perit Dial Int 21 (Suppl 3):S35-S40, 2001
3. HA H, CHA MK, CHOI HN, LEE HB: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22:171-177, 2002
4. KANG DH, HONG YS, LIM HJ, et al: High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-betal of human peritoneal mesothelial cells: Effect of cytokine costimulation. Perit Dial Int 19:221-230, 1999
5. HA H, YU MR, LEE HB: High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59:463-470, 2001
6. DE VRIESE AS, TILTON RG, STEPHAN CC, LAMEIRE NH: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 12:1734-1741, 2001
7. DE VRIESE AS, FLYVBJERG A, MORTIER S, et al: Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 14:2109-2118, 2003
8. LINDEN T, COHEN A, DEPPISCH R, et al: 3,4-dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 62:697-703, 2002
9. INAGI R, MIYATA T, YAMAMOTO T, et al: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 463:260-264, 1999
10. MURATA T, NAGAI R, ISHIBASHI T, et al: The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40:764-769, 1997
11. LU M, KUROKI M, AMANO S, et al: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-1224, 1998
12. HONDA K, NITTA K, HORITA S, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
13. PARK MS, LEE HA, CHU WS, et al: Peritoneal accumulation of AGE and peritoneal membrane permeability. Perit Dial Int 20:452-460, 2000
14. SCHMIDT AM, YAN SD, WAUTIER JL, et al: Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-497, 1999
15. TAKEDA K, NAKAMOTO M, YASUNAGA C, et al: The effects of electrolyte, lactate, high-concentrated glucose, and dialysate on peritoneal mesothelial cells. Adv Perit Dial 12:11-14, 1996
16. BREBOROWICZ A, MARTIS L, OREOPOULOS DG: In vitro influence of lactate on function of peritoneal flbroblasts. Adv Perit Dial 10:225-229, 1994
17. DE VRIESE AS, MORTIER S, CORNELISSEN M, et al: The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 22:566-572, 2002
18. MORTIER S, DE VRIESE AS, LEYSSENS A, et al: Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 23:331-338, 2003
19. OYA T, HATTORI N, MIZUNO Y, et al: Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 274:18492-18502, 1999
20. IKEDA K, HIGASHI T, SANO H, et al: N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083, 1996
21. DAVIES SJ, BRYAN J, PHILLIPS L, RUSSELL GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11:498-506, 1996
22. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
23. HEKKING LH, ZAREIE M, DRIESPRONG BA, et al: Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12:2775-2786, 2001
24. PARK MS, KIM JK, HOLMES C, WEISS MF: Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation. Perit Dial Int 20 (Suppl 5):S33-S38, 2000
25. BRUNKHORST R, MAHIOUT A: Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained integrity and proliferation of cultured human mesothelial cells. Kidney Int 48:177-181, 1995
26. MARGETTS PJ, GYORFFY S, KOLB M, et al: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728, 2002
27. NATARAJAN R, BAI W, LANTING L, et al: Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231, 1997
28. ZAREIE M, HEKKING LH, WELTEN AG, et al: Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol Dial Transplant 18:2629-2637, 2003
29. SCHALKWIJK CG, POSTHUMA N, TEN BRINK HJ, et al: Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 19:325-333, 1999
30. HONDA K, NITTA K, HORITA S, et al: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14:1541-1549, 1999
31. COMBET S, MIYATA T, MOULIN P, et al: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717-728, 2000
32. BOULANGER E, WAUTIER MP, WAUTIER JL, et al: AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 61:148-156, 2002
33. TANAKA N, YONEKURA H, YAMAGISHI S, et al: The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17 beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275:25781-25790, 2000
34. THROCKMORTON DC, BROGDEN AP, MIN B, et al: PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111-117, 1995
35. MANDL-WEBER S, COHEN CD, HASLINGER B, et al: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 61:570-578, 2002
36. SCHAMBYE HT, PEDERSEN FB, WANG P: Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: A cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 8:42-46, 1992
37. SCHALKWIJK CG, TER WEE PM, TEERLINK T: Reduced 1,2-dicarbonyl compounds in bicarbonate/lactate-buffered peritoneal dialysis (PD) fluids and PD fluids based on glucose polymers or amino acids. Perit Dial Int 20:796-798, 2000